Chemotherapy for gestational trophoblastic tumors.

Virtually 100% of patients with nonmetastatic and low-risk metastatic trophoblastic tumors are now curable by only conventional chemotherapeutic agents such as methotrexate, actinomycin D, or their combination with or without other agents. However, approximately 30% of high-risk patients with metastatic trophoblastic tumors are resistant to conventional chemotherapy. All of the high-risk patients resistant to chemotherapy are those with metastatic choriocarcinoma. Thus, the efficacy of multidrug chemotherapy and combination chemotherapy of cisplatin or VP16-213 with other agents is now being examined.

[1]  S. Goto,et al.  Recurrence of invasive moles and choriocarcinomas. , 2010, Asia-Oceania journal of obstetrics and gynaecology.

[2]  H. Ma,et al.  Methotrexate with citrovorum factor rescue in gestational trophoblastic disease. , 1985, American journal of obstetrics and gynecology.

[3]  D. Gershenson,et al.  High-Risk Metastatic Gestational Trophoblastic Disease , 1985, Obstetrics and gynecology.

[4]  Newlands Es.  VP-16 in combinations for first-line treatment of malignant germ-cell tumors and gestational choriocarcinoma. , 1985 .

[5]  J. Lewis,et al.  Late recurrence of gestational trophoblastic disease. , 1985, Gynecologic oncology.

[6]  S. Sekiya,et al.  Cell biology of choriocarcinoma. , 2010, Asia-Oceania journal of obstetrics and gynaecology.

[7]  Bagshawe Kd.  Treatment of high-risk choriocarcinoma. , 1984 .

[8]  R. Berkowitz,et al.  Modified triple chemotherapy in the management of high-risk metastatic gestational trophoblastic tumors. , 1984, Gynecologic oncology.

[9]  K. Leveno,et al.  Sinusoidal Fetal Heart Rate Pattern After Intrauterine Transfusion , 1984, Obstetrics and gynecology.

[10]  J. Schlaerth,et al.  Single-dose actinomycin D in the treatment of postmolar trophoblastic disease. , 1984, Gynecologic oncology.

[11]  E. Surwit,et al.  Poor‐Prognosis Gestational Trophoblastic Disease: An Update , 1984, Obstetrics and gynecology.

[12]  M. Sugita,et al.  Characterization of Human Choriocarcinoma Cell Lines Secreting High and Low Amounts of Chorionic Gonadotropin , 1983, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[13]  S. Sekiya,et al.  Effect of methotrexate on the growth and human chorionic gonadotropin secretion of human choriocarcinoma cell lines in vitro. , 1983, American journal of obstetrics and gynecology.

[14]  R. Berkowitz,et al.  Methotrexate with citrovorum factor rescue as primary therapy for gestational trophoblastic disease , 1982, Cancer.

[15]  J. Lurain,et al.  Gestational Trophoblastic Disease: Treatment Results at the Brewer Trophoblastic Disease Center , 1982, Obstetrics and gynecology.

[16]  J. Lee,et al.  Uterine choriocarcinoma with negative specific serum radioimmunoassay for human chorionic gonadotropins. , 1982, Gynecologic oncology.

[17]  L. Clayton,et al.  Chemotherapy with the modified Bagshawe protocol for poor prognosis metastatic trophoblastic disease. , 1982, Obstetrics and gynecology.

[18]  J. Weed,et al.  Gestational trophoblastic neoplasia , 1981, CA: a cancer journal for clinicians.

[19]  E. Surwit,et al.  Recurrent gestational trophoblastic disease. , 1981, Gynecologic oncology.

[20]  E. Surwit,et al.  Late recurrences of gestational trophoblastic neoplasia. , 1980, American journal of obstetrics and gynecology.

[21]  Hammond Cb,et al.  Treatment of metastatic trophoblastic disease with poor prognosis. , 1980 .

[22]  J. Schlaerth,et al.  Sustained remission of choriocarcinoma with cis-platinum, vinblastine, and bleomycin after failure of conventional combination drug therapy. , 1980, American journal of obstetrics and gynecology.

[23]  I. Jones,et al.  MEDIUM‐DOSE METHOTREXATE/FOLINIC ACID REGIMEN IN THE CHEMOTHERAPY OF GESTATIONAL TROPHOBLASTIC DISEASE , 1980 .

[24]  E. Newlands,et al.  Anti-tumour activity of the epipodophyllin derivative VP16-213 (etoposide: NSC-141540) in gestational choriocarcinoma. , 1980, European journal of cancer.

[25]  D. Boyes,et al.  Recurrence of metastatic trophoblastic disease after negative, plasma human chorionic gonadotropin beta-subunit assay. , 1980, Gynecologic oncology.

[26]  J. Lewis,et al.  Treatment of metastatic gestational trophoblastic neoplasms. A brief review of developments in the years 1968 to 1978. , 1980, American journal of obstetrics and gynecology.

[27]  K. Bagshawe,et al.  PREGNANCIES AFTER CHEMOTHERAPY FOR GESTATIONAL TROPHOBLASTIC TUMOURS , 1979, The Lancet.

[28]  H. Ma,et al.  Clinical trial of bleomycin in the treatment of gestational trophoblastic disease. , 1979, Gynecologic oncology.

[29]  E. Newlands,et al.  Activity of high-dose cis-platinum (NCI 119875) in combination with vincristine and methotrexate in drug-resistant gestational choriocarcinoma. A report of 17 cases. , 1979, British Journal of Cancer.

[30]  B. Wu,et al.  20 years experience in chemotherapy of choriocarcinoma and malignant mole. , 1979, Chinese medical journal.

[31]  E. Surwit,et al.  A new combination chemotherapy for resistant trophoblastic disease. , 1979, Gynecologic oncology.

[32]  P. Simkin,et al.  “Physiologic” Jaundice of the Newborn , 1979 .

[33]  R. Osathanondh,et al.  Methotrexate with citrovorum factor rescue for gestational trophoblastic neoplasms. , 1978, Obstetrics and gynecology.

[34]  A. Goldstein,et al.  Physiologic jaundice of the newborn. Relation to maternal serum and amniotic fluid alpha-fetoprotein. , 1978, Obstetrics and gynecology.

[35]  K. Bagshawe.  Risk and prognostic factors in trophoblastic neoplasia , 1976, Cancer.

[36]  R. Rebar,et al.  Limitation of the specific serum radioimmunoassay for human chorionic gonadotropin in the management of trophoblastic neoplasms. , 1976, American journal of obstetrics and gynecology.

[37]  G. Ross.  Congenital anomalies among children born of mothers receiving chemotherapy for gestational trophoblastic neoplasms , 1976, Cancer.

[38]  J. Smith.  Chemotherapy in gynecologic cancer. , 1975, Clinical obstetrics and gynecology.

[39]  R. Osathanondh,et al.  Actinomycin D as the primary agent for gestational trophoblastic disease , 1975, Cancer.

[40]  W. Jones.  Treatment of chorionic tumors. , 1975, Clinical obstetrics and gynecology.

[41]  J. Lewis,et al.  Treatment of gestational trophoblastic disease. , 1974, American journal of obstetrics and gynecology.

[42]  W. Creasman,et al.  Treatment of metastatic trophoblastic disease: good and poor prognosis. , 1973, American journal of obstetrics and gynecology.

[43]  A. Webster,et al.  Gestational trophoblastic disease. A comparative study of the results of therapy in patients with invasive mole and with choriocarcinoma. , 1971, American journal of obstetrics and gynecology.

[44]  D. V. van Thiel,et al.  Pregnancies after Chemotherapy of Trophoblastic Neoplasms , 1970, Science.

[45]  Hammond Cb,et al.  Diagnosis and treatment of trophoblastic disease. A report from the Southeastern Regional Center. , 1970 .

[46]  G. Ross,et al.  Primary chemotherapy for nonmetastatic gestational trophoblastic neoplasms. , 1967, American journal of obstetrics and gynecology.

[47]  P. Wei,et al.  The use of methotrexate in the treatment of trophoblastic diseases, especially choriocarcinoma. , 1967, American journal of obstetrics and gynecology.

[48]  J. Lewis,et al.  Treatment of trophoblastic disease. With rationale for the use of adjunctive chemotherapy at the time of indicated operation. , 1966, American journal of obstetrics and gynecology.

[49]  S. Perry,et al.  Lymphocyte transformation in mixed leukocyte cultures in women with normal pregnancy or tumors of placental origin. A preliminary report. , 1966, American journal of obstetrics and gynecology.

[50]  G. Ross,et al.  SEQUENTIAL USE OF METHOTREXATE AND ACTINOMYCIN D IN THE TREATMENT OF METASTATIC CHORIOCARCINOMA AND RELATED TROPHOBLASTIC DISEASES IN WOMEN. , 1965, American journal of obstetrics and gynecology.

[51]  J. Skom,et al.  CHEMOTHERAPY IN TROPHOBLASTIC DISEASES. , 1964, American journal of obstetrics and gynecology.

[52]  Lamb Ej,et al.  METHOTREXATE THERAPY OF CHORIOCARCINOMA AND ALLIED TUMORS. , 1964 .

[53]  Bagshawe Kd.  TROPHOBLASTIC TUMOURS. CHEMOTHERAPY AND DEVELOPMENTS. , 1963 .

[54]  R. Smith,et al.  Choriocarcinoma. Absolute 5 year survival rates of 122 patients treated by hysterectomy. , 1963, American journal of obstetrics and gynecology.

[55]  G. Ross,et al.  Actinomycin D in the treatment of methotrexate-resistant trophoblastic disease in women. , 1962, Cancer research.

[56]  C. Manahan,et al.  Amethopterin in the treatment of trophoblastic tumors. , 1961, American journal of obstetrics and gynecology.

[57]  J. Lewis,et al.  Five year's experience with the chemotherapy of metastatic choriocarcinoma and related trophoblastic tumors in women. , 1961, American journal of obstetrics and gynecology.

[58]  M. Li,et al.  Management of choriocarcinoma and related tumors of uterus and testis. , 1961, The Medical clinics of North America.

[59]  J. Holland,et al.  Treatment of malignant trophoblastic growth in women, with special reference to amethopterin. , 1961, American journal of obstetrics and gynecology.

[60]  M. Lipsett,et al.  Effect of Vincaleukoblastine on metastatic choriocarcinoma and related trophoblastic tumors in women. , 1960, Cancer research.

[61]  R. Hertz,et al.  Effect of Methotrexate Therapy upon Choriocarcinoma and Chorioadenoma , 1956, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.